Citalopram Hydrobromide

氢溴酸西酞普兰

Report date: 2022/10/19 13:54:45
NME

Base Information

Drug NameCitalopram Hydrobromide
Drug Alias NameCitalopramum西酞普兰氢溴酸盐Nitalapram氢溴西酞普兰西酞普兰 +[18] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin transporter inhibitors
TargetsSerotonin transporter
Therapy Area/IndicationsIschemic StrokeAgitationAutistic Disorder +[21] 
Global Approved IndicationsDepression
Approved Indications in ChinaDepression
Original Approved Country/TerritoryDenmark
Original Approved Date1989/01/01
Country/TerritoryCanadaUnited StatesRussian Federation +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesH. Lundbeck A/SForest Laboratories Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of MichiganAbbvie IncH. Lundbeck A/S
Inactive CompaniesNational Center For Complementary And Integrative HealthActavis IncTorrent Pharmaceuticals Ltd +[19] 
Active IndicationsDepressionParkinson Disease
Inactive IndicationsIschemic StrokeAgitationAutistic Disorder +[19] 

Other Information

ATC CodeN06AB04
Related LinksWikipediaDrugBankKEGG